Restrictive Blood Cell Transfusions Safe for Heart Surgery Patients

by Colleen Fleiss on  June 27, 2019 at 2:53 PM Heart Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

In patients undergoing cardiopulmonary bypass surgery a restrictive approach to blood cell transfusions was found to lead to fewer transfusions than a more liberal approach, without any increased risk of acute kidney injury. The results were consistent in patients with and without chronic kidney disease before surgery.The findings appear in an upcoming issue of JASN.
Restrictive Blood Cell Transfusions Safe for Heart Surgery Patients
Restrictive Blood Cell Transfusions Safe for Heart Surgery Patients

Washington, DC (June 20, 2019) -- In a recent clinical trial of higher risk patients undergoing cardiopulmonary bypass surgery, a restrictive approach to blood cell transfusions resulted in fewer transfusions without putting patients at increased risk of acute kidney injury. The findings appear in an upcoming issue of JASN.

Show Full Article


Reducing blood cell transfusions during surgery could prevent transfusion-related adverse effects, conserve the blood supply, and reduce healthcare costs, but it might also have negative effects on the kidneys due to a variety of mechanisms. To investigate, Amit X. Garg, MD, PhD, (Lawson Health Research Institute in Ontario) and his colleagues conducted a randomized clinical trial called TRICS-III. The trial included 4531 higher risk patients undergoing cardiopulmonary bypass surgery across 73 centers in 19 countries. Patients were randomized to a restrictive transfusion approach (transfuse only if hemoglobin is below 7.5 g/dL) or a more liberal approach (transfuse if hemoglobin is less than 9.5 g/dL).

Patients in the restrictive transfusion group received 38% fewer transfusions than patients in the liberal group (1.8 vs. 2.9 transfusions, on average, respectively), and the approaches were equally safe with respect to risk of acute kidney injury. Risk were similar between patients with and without chronic kidney disease before surgery.

"With over 20 million cardiac surgeries performed worldwide each year--with it being one of the more common reasons for using blood in the hospital and an average of about 3 units of red blood cells used per patient--this suggests that approximately 20 million units of blood transfusions could be avoided each year without influencing the chance that a patient will develop post-operative kidney injury," said Dr. Garg.

In an accompanying editorial, Iain Macdougall, MD, PhD (King's College Hospital, in the UK) and Toby Richards, MD (University of Western Australia) noted that the study represents one of the largest trials assessing acute kidney injury ever performed, but they pointed to several limitations.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Thalassemia Parkinsons Disease Surgical Treatment Coronary Artery Bypass Grafting Mitral valve Regurgitation and Mitral valve Replacement Heart Healthy Heart Statins Mitral Valve Prolapse Aortic Valve Stenosis Pericarditis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive